EASME

AGADE specializes in robotic exoskeletons. Its flagship product, AGADEXO, significantly reduces muscle fatigue and injury risks associated with repetitive tasks by providing variable support, mimicking zero-gravity movements.

A French startup created by CNRS researchers at the Physics and Mechanics of Heterogeneous Media (PMMH) Laboratory in Paris, Aenitis Technologies develops bioprocessing medical devices that use acoustophoresis to separate, manipulate and filter biological elements, with a focus on cell therapy manufacturing such as cell sorting, washing and isolation for cell therapy units and blood banks. The company aims to provide acoustic preparation solutions to streamline cell therapies and advance public health, pursuing leadership in acoustophoresis-based separation.

Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, that specializes in developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, addressing the needs of over 300 million patients worldwide affected by osteoarthritis. The company's flagship product, FibroFix, is a hydrogel implant designed to emulate human knee cartilage, enabling effective repair and regeneration of damaged tissues. Orthox offers several variations of FibroFix, including FibroFix Meniscus for meniscal cartilage repair and FibroFix Cartilage for articular cartilage damage. The implants promote integration with the body's cells, facilitating a return to active, pain-free living. With plans to expand its technology to other joints and additional applications beyond orthopaedics, Orthox is positioned to capitalize on the rapidly growing biomaterials market, projected to exceed $250 billion by 2025.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Neuro Device Group S.A. is a Polish med-tech company, established in 2008 and based in Warsaw, specializing in the development and manufacturing of medical devices aimed at addressing neurological disorders. The company's product lineup includes Neuro Device Camri, a diagnostic recording camera for MRI scanners; Neuro Device Scent, which measures neuronal reactions to scents; and Neuro Device Tacti, a stimulator used in preoperative fMRI diagnostics to localize brain sensomotoric areas. In addition to its proprietary devices, Neuro Device Group also distributes a range of high-quality neurological products and medical devices from leading global manufacturers, encompassing areas such as eye tracking, rehabilitation, virtual reality, and fMRI. The company's ongoing mission is to enhance neurological research and improve patient outcomes through innovative technologies.

mDurance is a digital health company that develops wearable electromyography (EMG) technology to assess and monitor muscle health for professionals in physical health, sports, and wellness. Its system combines a lightweight EMG sensor, Bluetooth-enabled device, mobile and web applications, cloud storage, and real-time data analytics to provide objective muscle data. The solution enables verification of muscle health through pattern analysis, real-time biofeedback on resistance, strength, and fatigue, and detection of muscle asymmetries to support rehabilitation and performance optimization. By synchronizing EMG data with video feedback, the platform helps healthcare and sports professionals monitor neuromuscular function, improve patient or athlete engagement, and guide evidence-based decisions without relying on subjective assessments.

Respinova is a developer of innovative non-invasive inhalation devices aimed at treating respiratory disorders, particularly chronic obstructive pulmonary disease (COPD). The company's flagship product, PulseHaler, utilizes a proprietary technology that generates dynamic air pressure pulses to target the core pathophysiology of COPD. These pressure pulses are designed to travel rapidly through the lung's airways, creating gentle dilating forces that help open collapsed airways and facilitate the clearing of mucus. By smoothing and spreading the mucus lining on the airway walls, PulseHaler assists in airway clearance and reduces the likelihood of airway re-closure, providing an effective treatment option for COPD patients.

Magentiq Eye Ltd., established in 2014, specializes in developing AI-driven medical devices for endoscopic procedures. Its flagship product is the Automatic Polyp Detection System (APDS), which uses computer vision and deep learning to assist doctors in real-time colonoscopy examinations, aiming to reduce polyp miss-rates and improve patient outcomes.

Cellestia Biotech AG is a biopharmaceutical company based in Basel, Switzerland, specializing in the development of innovative anti-cancer therapies. Founded in 2014 as a spin-off from EPFL in Lausanne, Cellestia focuses on its lead candidate, CB-103, an oral pan-NOTCH inhibitor designed to treat NOTCH-dependent leukemia, lymphoma, and solid tumors. The company is committed to advancing its research and development pipeline, which includes novel transcription factor inhibitors for oncology, autoimmune, and inflammatory disorders. Cellestia aims to enhance patient outcomes by developing NOTCH-specific biomarkers and diagnostics for more effective patient selection. With its emphasis on modulating pathogenic gene expression through selective inhibition of transcription factors, Cellestia is dedicated to pioneering breakthroughs in cancer treatment.

Vulcur Medtech is a medical device development company based in Vanløse, Denmark, established in 2018. The company specializes in wound healing through its innovative VulCur MedTech laser technology. This device is designed to target and eliminate biofilm-producing bacteria in chronic wounds by using laser pulses that penetrate tissue, effectively ablating bacteria while preserving human cells. By facilitating the healing of otherwise untreatable wounds, Vulcur Medtech's approach not only accelerates the healing process but also enhances patients' quality of life.

PlatoScience ApS is a Copenhagen-based company founded in 2015 that specializes in neurostimulation technology. It manufactures the PlatoWork headset, a plug-and-play device designed for transcranial direct current stimulation (tDCS). This non-invasive technology modulates neuronal activity by applying a low-intensity current to the scalp, allowing users to enter specific mindsets conducive to task completion. The company aims to make neurostimulation accessible and easy to use for everyone, facilitating improved mental health and enhanced cognitive performance. By providing a wearable device that sends small electronic signals to the brain, PlatoScience seeks to support users in achieving deep focus and effectively performing various tasks.

eLive Ecosystem specializes in developing innovative solutions aimed at preventing long-term diseases through advanced technology. The company has created an artificial intelligence-based medical device specifically designed for the self-measurement of sleep apnea, addressing diagnostic gaps and enhancing treatment monitoring. By integrating medicine, genomics, and advanced sensor technology, eLive aims to alleviate the pressures on healthcare systems caused by demographic changes and aging populations. Their platform focuses on enabling healthcare professionals to efficiently and cost-effectively manage disease prevention and treatment, ultimately improving patient outcomes on a global scale.

Kheiron Medical Technologies is a London-based medical technology company that develops Mia, an AI-powered mammography screening tool designed to help radiologists detect breast cancer. The system combines deep learning with radiology insights to improve detection efficiency, consistency, and accuracy across imaging workflows. Incorporated in 2016 and formerly known as Maesterai, the company maintains an international presence with offices in London, San Francisco, Budapest, and Amsterdam, aiming to advance precision radiology and improve outcomes for cancer patients.

Aspivix develops innovative medical devices aimed at enhancing safety and comfort in gynecological procedures. Its flagship product, CAREVIX, employs suction technology to gently stabilize the cervix during procedures, reducing pain and minimizing risks such as bleeding and infections.

Novagan Sàrl, established in Lausanne, Switzerland in 2009, specializes in the development and fabrication of III-nitride semiconductor epiwafers and optoelectronic devices. The company focuses on creating high-power electronics and ultraviolet-visible optoelectronics solutions, serving industries such as medical imaging, displays, and projection. Novagan aims to build long-term customer relationships by providing timely, reliable, and cost-effective services tailored to market demands.

Surgitate is a Turkish startup founded by Ozge Akbulut (PhD in Materials Engineering) and Barkın Eldem (MD, Thoracic Surgeon). They manufacture synthetic models for medical professionals and students to practice surgical procedures realistically. Their product range includes skin, breast, and vascular models designed to mimic incision, dissection, and suturing. Surgitate benefits from investments by Farplas, a leading automotive parts manufacturer, which aids in mass production processes, and Inovent, Turkey's first tech commercialization accelerator, facilitating connections with potential investors and customers.

Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Founded in 2009, Medlumics designs and manufactures catheter-based systems for treating supraventricular tachycardias. Utilizing optical coherence tomography technology, the company's products provide real-time, sectional information about tissue, enhancing procedural safety and efficacy.

Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Biom'Up designs, develops and manufactures absorbable medical devices based on collagen technology for biosurgery. The company offers Hemoblast products for hemostasis and related laparoscopic applicators, and Hemosnow solutions for guided tissue regeneration, serving orthopedics, spine, cardiac, general, maxillofacial, dental and other surgical specialties. It markets its products in Europe and the United States. Biom'Up was founded in 2005 and is based in Saint-Priest, France.

Spectroplast specializes in additive manufacturing of pure silicones using its proprietary SAMT technology. It offers customizable solutions for healthcare, industrial components, soft robotics, art, and medical sectors. Founded in 2018 as a spin-off from ETH Zurich, Spectroplasty enables cost-effective and time-saving production without the need for molds, operating with minimal waste.

ZygoFix is a medical device company specializing in spine technology. It has developed an innovative three-dimensional-printed implant designed to lock the facet joint of the lumbar spine. This device leverages the anatomy of the spine to provide stability, eliminating the need for traditional external screw-based bridges and reducing the reliance on pedicle screws. By doing so, ZygoFix aims to minimize the risks associated with improper screw placement, thereby enhancing safety in spinal surgeries. The company's focus on advancing spinal stability reflects its commitment to improving patient outcomes in the medical field.

CMI NOV SAS is a French healthcare company that specializes in designing, developing, and manufacturing medical devices for surgical applications. Founded in 2013 and based in Monistrol sur Loire, the company focuses on various medical fields, including cardiology, visceral surgery, gynecology, urology, and bariatrics. Notably, CMI NOV offers innovative solutions for mitral valve repair during open heart surgery, contributing to advancements in cardiac care. The company's commitment to enhancing surgical practices positions it as a key player in the medical device industry.

Probiomedica is a company focused on developing innovative biomedical devices that integrate engineering, biology, photonics, and robotics for health and personal care applications. The company specializes in creating small swallowable capsules designed to emit light at specific wavelengths, utilizing the principles of Photodynamic therapy. This technology aims to enhance the photo-killing of harmful bacteria such as Helicobacter pylori, which is associated with conditions like gastritis, peptic ulcers, and gastric cancer. By employing these advanced photonic techniques, Probiomedica seeks to offer effective treatments that minimize reliance on pharmaceuticals and reduce the risk of drug-related side effects, thereby improving patient outcomes in the realm of gastrointestinal health.

Nasal is a technology-focused company that specializes in developing automated medical devices for the healthcare sector. It aims to enhance professional practices by providing tools that offer detailed insights into the structure and behavior of the nasal cavity. Through its innovative solutions, Nasal seeks to advance medical simulation technology, thereby assisting and training healthcare professionals. The company's efforts are geared towards improving the quality of care for patients and supporting the ongoing development of medical expertise.

Cellcomb AB is a manufacturer based in Säffle, Sweden, specializing in environmentally friendly disposable laminate products. Established in 1980, the company focuses on producing items that meet high standards of hygiene, comfort, and safety, particularly for the food and healthcare industries. Its product range includes homeaway towels and bedding, food absorbers such as CELLSORB - ECO, CELLSORB - ACTIVE, and CELLSORB - MAX, as well as various hygiene and healthcare items like surgical laminates, mattress covers, and underlays. Cellcomb is recognized as one of Europe’s leading manufacturers in its sector, emphasizing flexibility, expertise, and environmental responsibility in its operations.

CardiacSense Ltd., founded in 2012 and based in Caesarea, Israel, develops innovative medical wearable devices aimed at monitoring heart arrhythmias and other critical health metrics. The company's FDA and CE certified medical watches and wristbands provide continuous, long-term, ambulatory, and non-invasive monitoring of vital functions, including heart rate, pulse rate, respiratory rate, core temperature, oxygen saturation, and blood pressure. Utilizing advanced PPG technology, CardiacSense's devices enable accurate real-time diagnostics for various medical conditions such as atrial fibrillation, hypertension, chronic obstructive pulmonary disease, heart failure, sleep apnea, and infections like COVID-19. By focusing on the prevention and early detection of cardiac events, CardiacSense aims to enhance healthcare delivery and improve patient outcomes.

Raytelligence AB is a Swedish company focused on developing advanced microwave sensors for the healthcare and industrial markets. Founded in 2015 as a subsidiary of Swedish Adrenaline, Raytelligence specializes in solutions that monitor vital signs such as heartbeat, movement, and body position. The company's flagship product, the RayVS1 sensor, is designed for home use and features capabilities for signal processing and analysis through a cloud service. In addition to its healthcare applications, Raytelligence has expanded into the industrial sector, securing clients in road construction and partnering with a major Swedish IT provider in the e-Health market. The team's expertise spans industrial design and radar signal processing, positioning Raytelligence as a key player in the development of innovative sensor technology.

Founded in 2005, Medfield Diagnostics specializes in manufacturing diagnostic instruments to enhance clinical outcomes. The company is renowned for its research on the application of microwave technology in stroke diagnostics, with notable products including Strokefinder.

Revamp Medical, founded in 2016, is dedicated to addressing the critical unmet needs of patients suffering from acute heart failure. With over one million annual admissions in the United States and associated costs exceeding $65 billion, the company aims to provide an innovative solution through its patented temporary catheter, Doraya™. This device regulates vascular hemodynamics, particularly for patients experiencing diuretic resistance, by managing preload and reducing central venous pressure. This functionality enhances diuretic efficacy and facilitates progressive decongestion, thereby allowing cardiologists to effectively manage key hemodynamic parameters. Revamp Medical is supported by a skilled team with extensive experience in the medical technology sector, positioning the company to make a significant impact in the treatment of acute heart failure.

Spectral Industries is a high-tech company that develops optical sensor systems for non-contact chemical analysis, enabling real-time, robust, in-line atomic analysis without sample preparation across industries such as food, medical, mining, and recycling. The company combines academic insight with practical development and collaborates with high-tech partners worldwide to create unique, mobile, and accurate solutions. Its product portfolio includes conveyor belt sensors, laser-induced breakdown spectroscopy engines, drill core scanners, and spectrometers designed for real-time analyses in harsh environments.

CreatSens develops a platform that provides paper-based creatinine and potassium potentiometric sensors solutions to the healthcare industry. It helps healthcare professionals to better manage the information that can be generated in primary care centers, doctor’s office or patient’s homes. CreatSens platform aims to improve the well-being of people by allowing the monitoring of relevant biochemical parameters of blood out of the lab. The biochemical and physical information will be integrated into a technological platform allowing an accurate prediction, early detection and better prevention of acute conditions from home. The company was founded in 2017 and is headquartered in Tarragona, Catalonia, Spain.

ConquerX is a biotechnology company focused on advancing precision medicine through innovative molecular profiling solutions for clinical trials. The company's flagship product, EbeGen, is an electro-chemical biosensor designed to detect multiple molecular targets, including DNAs, RNAs, and microRNAs, simultaneously without the need for sequencing or quantitative PCR, thus offering a cost-effective alternative to existing technologies. Additionally, ConquerX has developed a pan-cancer test that differentiates cancerous cells from healthy ones, utilizing high-throughput genomic and proteomic profiling alongside proprietary nanotechnology. This tool enables oncologists to effectively screen for commonly known biomarkers across various cancer types, thereby enhancing the cancer diagnosis process.

3DBattery is a company that specializes in the design, development, and manufacturing of innovative energy storage solutions. Founded in 2016 and based in Tel Aviv, Israel, it focuses on producing a variety of portable energy storage batteries, including rechargeable lithium-ion micro batteries, flexible batteries, and batteries integrated into chips. The company's products cater to the growing demands of flexible and portable electronic devices, such as wearable technology, energy harvesting devices, Internet of Things (IoT) applications, and medical devices. Additionally, 3DBattery aims to enhance energy and power density in its microbatteries through advanced material engineering techniques, addressing the needs of various industries, including electric vehicles and grid storage.

Raylytic GmbH is a software development company specializing in automated medical image analysis and clinical data extraction. Founded in 1999 and headquartered in Leipzig, Germany, with additional offices in Magdeburg, Raylytic offers the UNITY platform, which provides a fully integrated solution for clinical trial management and medical data collection. This web-based platform streamlines the setup and execution of clinical data collection tasks, including the management of case report forms and patient-reported outcome measures, while employing advanced algorithms for the precise analysis and quantification of radiological images. Raylytic's services encompass a range of activities, including clinical trials for medical devices, independent qualitative analysis, development of radiographic protocols, quality assurance, data management, and statistical reporting. The company's innovative approach combines industrial and medical image processing with machine learning, enabling efficient and accurate evaluation of medical images for evidence-based medicine and regulatory compliance.

WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

Healthplus.ai leverages electronic health record data to predict post-surgical complications, empowering healthcare professionals to proactively manage patient care, reduce complication impacts, improve outcomes, and lower costs.

Memetis GmbH, established in 2017 and headquartered in Karlsruhe, Germany, specializes in the development and production of foil-based miniature actuators. These innovative products utilize shape memory alloy technology, offering superior force generation, compactness, and flexibility compared to traditional wire-based mechanisms. Memetis serves diverse industries such as automotive, aerospace, medical technology, bioanalytics, and testing equipment manufacturing, catering to their unique motion control needs. As a spin-off of Karlsruhe Institute of Technology (KIT), the company leverages cutting-edge research to deliver high-performance solutions tailored to each client's requirements.

Innitius specializes in developing diagnostic devices aimed at enhancing women's health, particularly in the context of preterm birth. Utilizing innovative torsional ultrasound technology, the company has created a patented intravaginal probe that transmits torsional waves to assess changes in tissue consistency. This technology enables medical practitioners to evaluate the risk of preterm birth and the likelihood of successful labor induction. By providing actionable diagnostics, Innitius helps healthcare providers accurately identify false indications of premature labor, thereby improving patient care and outcomes in obstetrics.

Cyclomics is a Dutch startup dedicated to transforming cancer care by facilitating faster and more reliable diagnoses, particularly for cancer recurrence. It achieves this through its proprietary circulating tumor DNA (ctDNA) detection technology, CyclomicsSeq. Initially focused on head and neck cancers, the company aims to disrupt cancer diagnostics markets and clinical practices with its innovative solution.

Astraveus is developing the Lakhesys platform, an end-to-end cell foundry for cell and gene therapy manufacturing. The platform uses deep process optimization and single-use microfluidic bioprocessors to produce autologous therapies with reduced inputs and infrastructure needs, lowering costs and logistical barriers. By enabling automated, patient-specific biomanufacturing, Astraveus aims to improve access to transformative CGTs. The system builds equipment tailored for each patient to use autologous cells, leveraging microfluidic chip technology to convert cells into therapeutic agents. The approach seeks to scale production of cell and gene therapies while minimizing environmental impact and resource use, supporting more sustainable manufacturing at lower cost.

Saphenus has decoded phantom pain and enlarge gait stability through the sense of touch idea and the findings of the medicine nobel price 2021. Globally, millions of amputees face the devastating challenge of phantom pain, with no effective solution available until now. This constant, debilitating pain significantly impacts their quality of life. Saphenus has developed a groundbreaking technology that not only decodes phantom pain but also enhances mobility and stability through an innovative sensory feedback system, redefining what prosthetics can achieve. The urgency of our approach is underscored by the ongoing crisis in conflict zones like Ukraine-Russia and Israel-Palestina. These individuals urgently need faster, pain-free, and effective prosthetic solutions. With the establishment of our partnership with Ternopil Medical University in 2024, Saphenus is uniquely positioned to bring its innovation to those who need it most, offering renewed hope and quality of life. https://www.ukrinform.ua/rubric-regions/3916291-u-ternopoli-vijskovi-otrimali-innovacijni-priladi-do-proteziv-vid-avstrijskoi-kompanii.html Our technology is not just a medical breakthrough but a humanitarian imperative, poised to transform the lives of millions worldwide. Saphenus was awarded 2024 from the European Institute of Technology as one of the 6 best medtech startups in Europe.

Ovagen is a biotechnology company specializing in the commercial production of germ-free chicken eggs and birds. Primarily serving the pharmaceutical industry, Ovagen offers contract research services and expertise in specific poultry and rodent research technologies to Good Manufacturing Practice (GMP) standards.

EarWays Medical Ltd. is an innovative company focused on developing effective ear-care solutions aimed at improving the well-being of both children and adults. The company specializes in a medical device designed for the removal of earwax, utilizing a clinically proven and patented technology that features a flexible coated helical tip for easy navigation within the ear canal. This device facilitates cerumen extraction, management, and addresses earwax impaction, which can lead to temporary hearing loss. EarWays Medical offers user-friendly ear care products that are suited for both clinical environments and home use. The company is supported by a team of experts in bioengineering, medical devices, ear surgery, and hearing rehabilitation, positioning it to significantly enhance the accessibility and effectiveness of ear care solutions.

Pre Diagnostics is a Norwegian biomarker diagnostics company focused on the early detection of neurodegenerative diseases, especially Alzheimer’s disease. It develops blood-based in vitro diagnostic tests that capture disease-specific systemic responses, including intracellular analysis of monocytes to assess beta-amyloid clearance, with the aim of identifying disease onset before symptoms, improving patient stratification, and supporting precision medicine through laboratory services that back the diagnostic workflow.

Founded in 2014 through a collaboration between experts from the Langevin Institute and Georges Pompidou Hospital, Cardiawave develops non-invasive ultrasonic medical devices for treating heart valve diseases. Its flagship product uses real-time imaging and ultrasound technology to treat conditions like calcified aortic stenosis without thermal injury or invasive procedures.

Next Generation Sensors is a biotech business that creates mass spectrometers for commercial uses in the life sciences. Finding rapid, accurate screening information for potential health, security, and environmental hazards relies on. By bringing the lab to the sample with portable, sensitive, accurate, and user-friendly technology for quick detection of dangerous compounds in our food, bodies, and environment, offers answers for a safer future.

Founded in 2019, AnnAidA Technologies specializes in developing innovative devices for biochemical research. Its flagship product, EmbryoSpin, enables chemical analysis at the scale of a single human embryo using microscopic Nuclear Magnetic Resonance technology.

Cardioset Medical is a group of scientists and business people who strive to make a life-changing impact on patients suffering from heart failure lung edema. With over 15 years of research and development we now have the solution that can literally revolutionize millions of HF patients' lives by enabling them to self-monitor their lung edema state and detect small changes at an even earliest stage.

liberDi is an Israeli company that specializes in developing portable automatic peritoneal dialysis systems for patients with end-stage renal disease. The company has created a comprehensive Digital Dialysis Clinic that enables patients to manage their own dialysis care with the assistance of an Intelligent Dialysis Assistant and remote medical supervision. This innovative self-care system allows patients to perform dialysis conveniently from various locations, such as their homes or while traveling, thereby enhancing their quality of life. Founded in 2014, liberDi aims to transform the traditional dialysis model by providing a safe, patient-friendly alternative to in-clinic care. The company's technology not only empowers patients but also helps clinics optimize their operations, improve service quality, and reduce costs, establishing a holistic platform for renal patients and their caregivers.

Vibrosonic GmbH is a company specializing in the development, production, and marketing of advanced hearing solutions aimed at addressing various levels of hearing impairment. As a spin-off from the Fraunhofer Project Group for Automation in Medicine and Biotechnology and the University ENT Clinic in Tübingen, Vibrosonic focuses on innovative technologies that enhance the auditory experience for users. The company has created hearing contact lenses that utilize microsystem technology and a piezoelectric principle, enabling sound transmission through vibrations directly to the eardrum. This approach offers a discreet alternative to traditional hearing aids, improving comfort and usability for individuals with hearing loss.

PlumeSTARS is a specialized pharmaceutical company focused on developing innovative drug delivery systems targeting lung diseases. Its primary focus is on treating respiratory infections, particularly in patients with Cystic Fibrosis.

BioMensio develops smart handheld devices for rapid, on-site detection of multiple biological targets. Its core technology enables label-free assays and facilitates development of new bio-screening applications. The company's products include BioMensio devices and a novel miniaturized microarray platform, serving point-of-care, food safety, and bio-security applications.

MyoSwiss is a Swiss medtech company that develops robotic and textile technology to help people with muscle weakness regain mobility and independence. The company manufactures the Myosuit and Myofit training devices used in rehabilitation and physiotherapy to improve walking and running ability. It offers individualized training plans, intensive and activity-based training, and performance tracking, along with a multifunctional training device that provides an additional layer of muscle support for mobility-impaired patients. Founded in 2017, the company is based in Zurich, Switzerland.

BrainPatch is a neurotechnology company developing a computer-brain interface to measure brain activity. Its platform combines AI, hardware, and applications for professionals and patients, aiming to enable early detection of non-invasive brain stimulation methods for neurological disease recovery.

Scandinavian ChemoTech AB is a clinical development company headquartered in Lund, Sweden. It specializes in cancer care and pain management solutions, primarily through its innovative product, IQWave. This electroporation device uses short electric pulses in conjunction with localized or intravenous chemotherapy to treat various cancers, including head and neck squamous cell carcinoma, malignant melanoma, and breast adenocarcinoma, among others. The company's founders bring extensive experience in surgical oncology and clinical research, driving its commitment to advancing cancer treatment through genuine research and clinical trials. ChemoTech markets its products via distribution channels and a network of opinion leaders across regions such as South East Asia, India, and the Philippines. Established in 2013, the company continues to focus on developing effective therapies for cancer patients.

ODI Medical is a developer of advanced medical technology focused on the bedside evaluation of circulatory failure through the assessment of microcirculation. The company's innovative devices streamline the collection of microvascular data, facilitating a variety of clinical applications. These include monitoring patients on mechanical heart and lung machines, evaluating the toxicity of chemotherapy, early detection of evolving sepsis, and monitoring chronic wounds. Additionally, ODI Medical's technology supports mass screening for infectious conditions such as Ebola, bird flu, and epidemic meningitis. By utilizing non-invasive methods, the company enables medical researchers to enhance patient therapy through a better understanding of microcirculation.

Nateo Healthcare is a Toulouse, France-based medical technology company that designs, develops, and manufactures connected devices and software for obstetrics and gynecology. Founded by obstetricians, gynecologists and medical technology specialists, the company focuses on portable fetal monitoring solutions, including compact mobile fetal heart and uterine activity monitoring systems, and remote patient monitoring for maternity care. Its products enable continuous fetal heart rate and uterine activity assessment, support telemonitoring for home use or hospital settings, and aim to optimize bed utilization in maternity wards while enhancing patient well-being through more flexible care. By integrating wireless connections and real-time data, Nateo Healthcare seeks to provide clinicians with mobile, connected CTG monitoring capabilities and to expand access to monitoring in hospitals and at home.

Yakna develops neurorehabilitation applications and hardware professional education popularization of science.

Diapath S.p.A. is a privately held company that specializes in the anatomic pathology sector, providing a range of high-quality products and customized services to hospitals and laboratories globally. The company manufactures reagents, medical instruments, and consumables designed for modern anatomical and cytology laboratories. Its product lineup includes high-tech instruments, stains, tissue processing dyes, and microtomy supplies, all developed to meet rigorous quality standards. With a commitment to innovation and reliability, Diapath aims to establish itself as a leading brand in anatomic pathology, emphasizing customer needs and delivering tailored solutions.

Somax Systems specializes in developing and marketing advanced ultrasound imaging devices tailored for healthcare professionals. Their flagship product is a compact, versatile scanner poised to become an indispensable tool akin to current staples like stethoscopes or thermometers. The company's core values include trust, innovation, quality, and sustainability, guiding their pursuit of superior imaging solutions that meet evolving healthcare needs.

Stemcis is a medical device manufacturer based in Saint-Denis, France, specializing in the research and development of adipose tissue applications for both human and veterinary medicine. The company focuses on creating surgical kits designed for the collection, treatment, and re-injection of fat cell preparations. Through its innovative protocols and products, Stemcis aims to address various medical conditions by leveraging the therapeutic potential of adipose tissue. The company's expertise in tissue engineering plays a crucial role in advancing treatments for multiple pathologies.

Waterscope is a not-for-profit impact-defined company based in Cambridge. Waterscope is a Cambridge University spin-out developing easy-to-use, rapid water testing microscopes capable of identifying bacterial presence in drinking water. Their bacterial imaging device can identify specific bacterial micro-colonies in less than 6 hours, four times faster than current gold-standard portable systems. Their system is automated, not requiring significant user training. Using image recognition software, bacterial colonies can be automatically identified and counted. Once data is collected the bacterial imaging device will automatically upload and disseminate results for mapping or intervention. THeir novel bacterial cartridge simplifies bacterial testing eliminating the need for a central lab and significant user training.

BalanSeat is a medical device developed by MoPair Technologies Ltd., a company founded by a Feldenkrais practitioner with extensive experience in treating neurologically impaired patients, including those with Multiple Sclerosis, Post-Stroke effects, and Parkinson’s disease. The device is designed specifically for the elderly and individuals with neurological impairments, aiming to enhance walking quality, improve balance, and reduce the risk of falls. BalanSeat achieves this by applying rotational movement between the pelvis, trunk, and thighs, which emulates normal walking patterns while the user remains seated. This innovative approach helps older adults regain essential balance and upper-body rotational movement, contributing to their overall mobility and safety.

Espansione Group is a medical technology company specializing in the development and distribution of innovative, non-invasive devices for ophthalmology. Their product portfolio includes proprietary photobiomodulation devices, light therapy systems using red, blue, and ultraviolet light, and diagnostic tools for eye screening. These solutions are designed to enhance patient outcomes by leveraging advanced, science-driven therapies, primarily serving the ophthalmology field.

Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

Hystrix Medical operates a digital marketplace designed to streamline the procurement process for medical devices and repeat purchase products within hospitals. The platform connects healthcare organizations with suppliers, significantly reducing the typical 4-6 month contracting timeline by providing a comprehensive one-stop shop that establishes a transparent market price landscape. It focuses on medical products that require minimal explanation for transaction, aiming to enhance the efficiency of hospital personnel and suppliers. By facilitating easier and more effective procurement and sales, Hystrix Medical has demonstrated an average total cost savings of 40% for its users, making it a valuable resource in the healthcare supply chain.

Capitainer is a Swedish medical device company that develops volumetric blood collection devices for fixed-volume dried blood spots collected at home. The device enables patients to remotely collect a predefined blood volume, which can be mailed to a laboratory for analysis. The technology aims to reduce patient travel and healthcare resources required for blood sampling, while delivering improved accuracy over conventional methods and offering cost and environmental savings for healthcare providers handling large volumes of samples. Founded in 2016 and based in Stockholm, Capitainer focuses on enabling convenient, safe, and reliable remote blood collection for quantitative testing.

AFYX Therapeutics A/S is a pharmaceutical company based in Copenhagen, Denmark, focused on developing and manufacturing treatments for mucosal diseases. Established in 2014, the company is known for its flagship product, the Rivelin® patch, which is designed for the treatment of oral lichen planus. This innovative patch is flexible, biodegradable, and adheres to mucosal surfaces, utilizing electrospinning technology to deliver medication directly to the affected area. By offering targeted therapies for conditions that currently lack approved treatment options, AFYX Therapeutics aims to enhance patient relief and support recovery without disrupting daily activities.

Regentis Biomaterials Ltd. is a company specializing in tissue repair, particularly in the development and commercialization of biodegradable hydrogels for repairing damaged cartilage tissue. Founded in 2004 and based in Or-Akiva, Israel, with an additional office in Princeton, New Jersey, the company’s core technology includes Gelrin, a hydrogel matrix composed of polyethylene glycol diacrylate and denatured fibrinogen. This innovative platform merges the stability of synthetic materials with the bio-functionality of natural substances, catering to various clinical applications. Regentis's flagship product, GelrinC, is designed for treating articular cartilage lesions and is currently undergoing clinical trials. The company’s focus is on orthopedic treatments, aiming to restore health and improve the quality of life for patients suffering from cartilage damage and related conditions.

Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, that specializes in developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, addressing the needs of over 300 million patients worldwide affected by osteoarthritis. The company's flagship product, FibroFix, is a hydrogel implant designed to emulate human knee cartilage, enabling effective repair and regeneration of damaged tissues. Orthox offers several variations of FibroFix, including FibroFix Meniscus for meniscal cartilage repair and FibroFix Cartilage for articular cartilage damage. The implants promote integration with the body's cells, facilitating a return to active, pain-free living. With plans to expand its technology to other joints and additional applications beyond orthopaedics, Orthox is positioned to capitalize on the rapidly growing biomaterials market, projected to exceed $250 billion by 2025.

ABLE Human Motion is a Barcelona-based medical device company founded in 2018. It specializes in developing robotic exoskeletons, with its flagship product being the ABLE Exoskeleton. This wearable technology actively assists paraplegic individuals to stand up, walk, and sit down, aiming to enhance rehabilitation efficiency for clinicians and empower users with greater mobility and independence.

BioCom is a highly innovative Company in the biomedical sector, focused on research, development and manufacture of cutting-edge medical devices, as well as the development of new technologies for surgery, diagnostics and biomedical research.

Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.

TransCure BioServices SAS is a biotechnology company based in Archamps, France, founded in 2012. The company specializes in vivo pharmacology preclinical services and offers unique research and development platforms, including its Humanized Immune System (HIS) and Human Immunodeficiency Virus (HIV) mouse models. These innovative models are designed to enhance the drug profiling and development process for pharmaceutical companies, biotech firms, and academic researchers focusing on immuno-related diseases and anti-HIV/AIDS therapies. By providing access to its specialized platforms as fee-for-service offerings, TransCure BioServices enables clients to efficiently generate and characterize humanized mouse models that deliver predictive insights into human drug responses. This capability helps accelerate the development and commercialization of new therapies, ultimately allowing clients to bring effective treatments to market more quickly and cost-effectively.

TRiCares is a medical device company focused on creating innovative solutions for tricuspid valve regurgitation. The company specializes in developing a catheter-based valve replacement system that facilitates minimally invasive treatments for patients suffering from tricuspid insufficiency. By emphasizing anatomical conformation and user-friendly design, TRiCares aims to provide effective and durable treatment options that improve patient outcomes. Through its advancements in medical technology, TRiCares addresses a critical need in cardiology, enhancing the quality of care for those affected by this condition.

SurGuide is a medical device company with the goal to improve the surgical care for cancer patients. They support surgeons in their aim to achieve complete tumor removal, which is the biggest challenge in cancer surgery. Incomplete tumor removal, negatively affects patient outcome and necessitates additional treatment1. SurGuide’s technology addresses the problem that the information about the result of the operation becomes available only after several days. SurGuide’s technology will enable inspection of the resected tissue to determine if a tumor has been completely removed. The result of this inspection is reported to the surgeon, while the patient is still in the operating room. The report shows at which locations the tumor has not been completely removed. Based on this critical feedback the surgeon can decide to perform an additional resection at the indicated locations. In this way SurGuide’s technology will help to increase the rate of complete tumor resections.

Eucardia specializes in the development of a groundbreaking medical device known as the Heart Damper. This minimally invasive implantable cardiac device is designed to address the needs of patients suffering from advanced heart failure. By offering a straightforward and cost-effective therapeutic solution, Eucardia aims to enhance both the duration and quality of life for these patients. Additionally, the Heart Damper contributes to lowering healthcare costs associated with advanced heart failure management, making it a significant advancement in cardiac care.

DermoSafe is a Swiss company founded in November 2012 by Philippe Held, located in Cheseaux, Switzerland. The company specializes in innovative products and services aimed at the early detection and management of melanoma. DermoSafe manufactures medical devices that capture high-definition dermoscopic images of moles and pigmented lesions, facilitating a straightforward process for general practitioners. Through a secure web application, practitioners can enter patient data and send images to dermoscopy specialists for analysis. These specialists provide their assessments in documented electronic reports, enabling healthcare professionals to identify melanoma at an early stage and effectively manage treatment.

Biocompatibility Innovation (BCI), established in 2014 in Padua, Italy, specializes in biotechnologies for biomedical applications. The company develops and manufactures highly biocompatible implantable prostheses, both biological and polymeric, using its proprietary FACTA® and PROTEGO technologies. These innovations extend the lifespan of bioprostheses and enhance the biocompatibility of implantable medical devices. BCI also provides third-party testing services and develops new proprietary treatments. Led by experienced researchers and managers in biotech and biomedicine, BCI aims to improve clinical management, patient quality of life, and lower healthcare costs.

Delmic is a company specializing in correlative light and electron microscopy technology, catering to the needs of life and materials science research. It offers a range of advanced services, including cathodoluminescence, integrated and automated cryo-electron tomography workflows, and rapid electron microscopy solutions designed for reliability and high throughput. By providing integrated correlative microscopy, Delmic equips researchers and organizations with effective and user-friendly tools, enabling them to obtain insights more efficiently and with greater ease.

Founded in 2015, Bambi Medical is a MedTech company dedicated to reducing pain and stress in premature infants while enhancing parent-child bonding. It specializes in designing, developing, and manufacturing innovative products for Neonatal Intensive Care Units.

Bioengineering Laboratories SRL, based in Cantu, Italy, specializes in designing, developing, manufacturing, and distributing a range of medical devices. Its product portfolio includes urodynamic, dialysis, gynecology, extracorporeal, cardiac surgery, and micro molding products. With over two decades of experience and a team of professional engineers, the company focuses on innovative design, market knowledge, regulatory compliance, and quality systems to create dedicated life-saving medical devices. Additionally, Bioengineering Laboratories offers advisory services for the design, industrialization, and production processes of medical devices.

Gogoa Mobility Robots specializes in developing wearable robotic solutions aimed at enhancing human mobility and supporting rehabilitation efforts. The company focuses on creating affordable and effective products, including exoskeletons designed for both industrial applications and health-related challenges. Their award-winning "Assist-As-Needed" control technology allows for seamless adaptation to various human movements, translating intention into action. Gogoa's exoskeletons are utilized in physical rehabilitation for patients recovering from conditions such as acquired brain damage, stroke, and spinal cord injuries, as well as in manufacturing to improve worker mobility and reduce injury risks. The Hank exoskeleton, a key product, has received CE Mark certification, enabling its commercial sale across Europe.

Gondola Medical Technologies SA is a Swiss company dedicated to the research and development of innovative medical devices aimed at enhancing rehabilitation for individuals with neurological and osteoarticular conditions. Founded in 2011 and headquartered in Stabio, the company has created the GONDOLA medical device, which employs Automated Mechanical Peripheral Stimulation (AMPS) to address motor symptoms associated with Parkinson's disease. This non-invasive device targets issues such as freezing of gait, slowness of movement, and balance difficulties. The GONDOLA device is designed for short-term use, allowing patients to wear it on their feet for a few minutes, and can be utilized in both home environments and clinical settings. Regular use of the device, ideally twice a week, sustains its therapeutic benefits, which can last from three to five days after treatment.

Dicronis develops innovative diagnostic tools. Its flagship product, Lymphit, is a wearable device that tracks lymphatic function safely and remotely, enabling early diagnosis of secondary lymphedema, a common side effect of cancer therapies.

Chromition Limited, established in 2014 and headquartered in Manchester, UK, specializes in developing and supplying advanced nanoparticle solutions for various commercial applications. The company's portfolio includes Luminspheres, multi-colored photoluminescent polymer nanoparticles used in bio-imaging, anti-counterfeit measures, and lighting; Elecspheres, semiconductor polymer nanoparticle aqueous inks applied in displays, electronics, lighting, solar cells, and sensors; and Dielecspheres, high-k dielectric films that allow electronic devices to function at ultra-low voltages and low power. Chromition's technology originated from research at the University of Manchester and has been commercialized for next-generation optoelectronic products.

CorAssist Cardiovascular Ltd. is a clinical stage medical device company based in Haifa, Israel, focused on developing innovative products for treating heart failure with preserved ejection fraction and diastolic dysfunction. The company offers CORolla, an elastic self-expanding device designed to be implanted inside the left ventricle through minimally invasive procedures, including transapical and percutaneous approaches. This device enhances cardiac diastolic function by improving diastolic dynamics and filling performance without the need for an external power source. Additionally, CorAssist's ImCardia is a device that attaches to the external surface of the left ventricle and is implanted through a straightforward off-pump procedure, further contributing to the improvement of diastolic function in heart patients. Founded in 2003, CorAssist aims to address the unmet needs in heart failure treatment through its proprietary technology.

TPC Components AB is a prominent investment casting foundry located in Hallstahammar, Sweden, specializing in the production of high-quality investment castings. The company manufactures components such as stator and rotor blades, multi-airfoil nozzles, and structural parts made from cobalt- and nickel-based alloys, which are cast in vacuum or air. TPC Components serves a diverse range of industries, including engineering, automotive, and gas turbines, supplying installation-ready parts for applications in extreme environments. Their products are utilized in gas turbines, automotive transmissions, and various equipment within the food, pharmaceutical, and petrochemical sectors. With a strong emphasis on meeting customer needs, TPC Components has cultivated a culture of reliability and excellence, ensuring that their components perform effectively in both demanding and conventional applications.

Syrinjector LTD. is developing a full digital solution based on a novel portable automated syringe gun and software for rapid, controlled, and traceable mass injection of livestock. With digital capabilities and data management, this fully automated, highly accurate, and safety-conscious solution is a must for the next generation of livestock farmers. Their solution will gradually replace the current process of using steel syringe guns and off-line paper certifications.

Founded in 2014 and headquartered in Jena, Germany, Preventicus develops certified medical device software for smartphones and smartwatches. Its primary product, Preventicus Heartbeats, identifies atrial fibrillation for stroke prevention by analyzing patients' vital parameters, enabling early detection of lifestyle-related illnesses.

RoboFit ApS is a Danish company located in Christiansfeld that specializes in the development and marketing of a rehabilitation robot designed for individuals with limited muscle strength. This innovative technology facilitates effective shoulder rehabilitation by enabling patients to exercise through the full range of motion. The company's focus is on providing measurable and motivational support during rehabilitation sessions, enhancing the overall recovery experience for patients with shoulder injuries or conditions.

Filterlex Medical is a medical device company focused on cardiovascular embolic protection. It develops embolic protection devices to reduce the risk of stroke and other embolic complications during catheter-based structural heart procedures, including transcatheter aortic valve implantation. Its CAPTIS full-body embolic protection device is designed for intuitive deployment and retrieval and is compatible with multiple catheter sizes, enabling integration into existing workflows. The company aims to improve patient safety during minimally invasive heart valve replacement procedures. It was founded in 2015 and is based in Yokneam, Israel.

Rithmi develops innovative, non-invasive technology for real-time arrhythmia detection. Its pioneering product aims to revolutionize stroke prevention by providing accurate heart pulse data through light reflection on the skin, closely matching ECG accuracy.

AcouSort develops and sells laboratory equipment and integrated solutions using ultrasound to separate, wash, and enrich cells, exosomes, and other biological particles for research and diagnostics.

Founded in 2014 and based in Ecublens, Switzerland, SamanTree Medical develops digital microscopy systems using micro-optics for research, diagnostics, and surgeries. Its flagship product is a surgical digital microscope that enables real-time visualization of living tissue structure, enhancing surgical decision-making and reducing re-operation rates.

Trisol Medical is a medical device company focused on addressing tricuspid regurgitation through innovative treatment solutions. The company specializes in the development of a transcatheter tricuspid replacement valve, which is engineered from a nitinol frame and features specially designed leaflets. This design effectively eliminates tricuspid regurgitation while preserving the function of the right ventricle. Trisol Medical's offerings aim to provide comprehensive treatment for patients suffering from tricuspid regurgitation and associated right ventricle dysfunction, enhancing patient outcomes and quality of life.

Nimble Robotics designs and sells innovative medical devices for rehabilitation.

Neurosteer develops a wearable device and cloud-based system for early detection and effective treatment of neurological disorders. It uses an adhesive forehead strip connected to a pocket-sized device, transmitting data wirelessly for real-time brain activity analysis. The solution aims to provide affordable screening, continuous patient monitoring, and optimized neurostimulation and drug selection, improving neurological treatment outcomes.

GyroGear is a team of designers, engineers, and medics developing the GyroGlove, a wearable device that mechanically stabilizes hand tremors using aerospace-grade gyroscopes. Their mission is to improve independence, dignity, and quality of life for individuals with Parkinson's disease and Essential Tremor.